Literature DB >> 10819835

Laparoscopic removal of a transabdominal cervical cerclage.

S E Scarantino1, J G Reilly, M L Moretti, V T Pillari.   

Abstract

Cervical incompetence has been acknowledged as a significant entity predisposing patients to second-trimester miscarriage. Various surgical techniques and approaches have been used in an attempt to prolong pregnancy and improve perinatal outcome. These include transvaginal and transabdominal cervical cerclage. Some patients require the placement of a transabdominal cervicoisthmic cerclage. Should the cerclage fail or the patient have preterm premature rupture of membranes, removal of the cerclage may be necessary. As a result the application of laparoscopy for the management of cervicoisthmic cerclage removal has been advocated in an effort to limit surgical complications. We report a case of laparoscopic removal of a transabdominally placed cervical cerclage in a 32-year-old woman at 16 weeks' gestation with preterm premature rupture of membranes and inevitable miscarriage. Laparoscopy appeared to be a safe and effective means of managing the removal of this transabdominally placed cervicoisthmic cerclage.

Entities:  

Mesh:

Year:  2000        PMID: 10819835     DOI: 10.1067/mob.2000.105404

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Laparoscopic removal of abdominal cerclage at 19 weeks' gestation.

Authors:  James F Carter; Ashlyn Savage; David E Soper
Journal:  JSLS       Date:  2013 Jan-Mar       Impact factor: 2.172

2.  Laparoscopic removal of abdominal cervical suture.

Authors:  Mark McComiskey; James C Dornan; David Hunter
Journal:  Ulster Med J       Date:  2006-09

3.  Removal of laparoscopic cerclage stitches via laparotomy and rivanol-induced labour: A case report and literature review.

Authors:  Xin-Ni Na; Ben-Shuo Cai
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

4.  Laparoscopic removal of abdominal cerclage.

Authors:  James F Carter; David E Soper
Journal:  JSLS       Date:  2007 Jul-Sep       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.